Stuart C. Wilson
Impact in
- Organic Chemistry top 10%
- Quinazolinone synthesis and applications
- Multicomponent Synthesis of Heterocycles
- Synthesis and Biological Evaluation
- Synthesis and pharmacology of benzodiazepine derivatives
-
- Endoplasmic Reticulum Stress and Disease
Papers in
-
- Cancer therapeutics and mechanisms 3
- Biochemical and Molecular Research 2
- Oncology 7
- Cancer-related Molecular Pathways 6
- Lung Cancer Research Studies 1
- Co-authors
- Ann L. Jackman (3 shared papers)Vassilios Bavetsias (3 shared papers)Paul Workman (7 shared papers)Davinder S. Theti (2 shared papers)Amin Mirza (2 shared papers)Ian R. Hardcastle (1 shared paper)Philip W. Howard (2 shared papers)Mike I. Walton (1 shared paper)
- Journals
- Molecular Cancer Therapeutics (2 papers)Bioorganic & Medicinal Chemistry (2 papers)Journal of Medicinal Chemistry (2 papers)Cancer Research (2 papers)Molecular Oncology (1 paper)
- Partner nations
- United KingdomUnited States
In The Last Decade
Stuart C. Wilson
13 papers receiving 509 citations
Peers
Comparison fields: 5 of 70
- Organic Chemistry 211
- Cell Biology 81
- Oncology 120
- Molecular Biology 275
- Inorganic Chemistry 35
Countries citing papers authored by Stuart C. Wilson
This map shows the geographic impact of Stuart C. Wilson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stuart C. Wilson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stuart C. Wilson more than expected).
Fields of papers citing papers by Stuart C. Wilson
This network shows the impact of papers produced by Stuart C. Wilson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stuart C. Wilson. The network helps show where Stuart C. Wilson may publish in the future.
Co-authors
The 25 scholars most cited alongside Stuart C. Wilson, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2006 | 129 | |
| 2 | 2012 | 88 | |
| 3 | 1999 | 62 | |
| 4 | 2005 | 57 | |
| 5 | 2005 | 52 | |
| 6 | 2017 | 32 | |
| 7 | 2011 | 28 | |
| 8 | 2005 | 27 | |
| 9 | 2002 | 26 | |
| 10 | 1995 | 9 | |
| 11 | 2001 | 7 | |
| 12 | Abstract #3863: Derivatives of seliciclib with improved potency both in vitro and in vivo as novel cyclin dependent kinase (CDK) inhibitors | 2009 | 1 |
| 13 | Novel cyclin dependent kinase (CDK) inhibitors induce down regulation of Mcl-1 and apoptosis in multiple myeloma cells | 2006 | 1 |
About Stuart C. Wilson
Stuart C. Wilson is a scholar working on Molecular Biology, Oncology, Organic Chemistry, Pulmonary and Respiratory Medicine and Cell Biology, having authored 13 papers that have together received 519 indexed citations. Recurring topics across this work include Cancer-related Molecular Pathways (6 papers), Advanced Breast Cancer Therapies (5 papers), Cancer therapeutics and mechanisms (3 papers), Quinazolinone synthesis and applications (3 papers), Synthesis and pharmacology of benzodiazepine derivatives (2 papers), Synthetic Organic Chemistry Methods (2 papers), Biochemical and Molecular Research (2 papers) and Lung Cancer Research Studies (1 paper). The work is most often cited by research in Organic Chemistry (211 citations), Cell Biology (81 citations), Oncology (120 citations), Molecular Biology (275 citations) and Inorganic Chemistry (35 citations). Stuart C. Wilson has collaborated with scholars based in United Kingdom and United States. Frequent co-authors include Ann L. Jackman, Vassilios Bavetsias, Paul Workman, Davinder S. Theti, Amin Mirza, Ian R. Hardcastle, Philip W. Howard, Mike I. Walton, David E. Thurston and Jonathan J. Turnbull. Their work appears in journals such as Molecular Cancer Therapeutics, Bioorganic & Medicinal Chemistry, Journal of Medicinal Chemistry, Cancer Research and Molecular Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.